skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Bulk production and evaluation of high specific activity 186g Re for cancer therapy using enriched 186 WO 3 targets in a proton beam

Journal Article · · Nuclear Medicine and Biology

Rhenium-186 g (t1/2 = 3.72 d) is a β– emitting isotope suitable for theranostic applications. Current production methods rely on reactor production by way of the reaction 185Re(n,γ)186gRe, which results in low specific activities limiting its use for cancer therapy. Production via charged particle activation of enriched 186W results in a 186gRe product with a much specific activity, allowing it to be used more broadly for targeted radiotherapy applications. Furthermore, this targets the unmet clinical need for more efficient radiotherapeutics.

Research Organization:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Organization:
USDOE Office of Science (SC), Nuclear Physics (NP)
Grant/Contract Number:
AC52-06NA25396
OSTI ID:
1345946
Alternate ID(s):
OSTI ID: 1415249
Report Number(s):
LA-UR-16-29352; TRN: US1700520
Journal Information:
Nuclear Medicine and Biology, Vol. 49, Issue C; ISSN 0969-8051
Publisher:
ElsevierCopyright Statement
Country of Publication:
United States
Language:
English
Citation Metrics:
Cited by: 16 works
Citation information provided by
Web of Science

References (30)

Preclinical evaluation of isostructural Tc-99m- and Re-188-folate-Gly-Gly-Cys-Glu for folate receptor-positive tumor targeting journal March 2016
Preparation and first biological evaluation of novel Re-188/Tc-99m peptide conjugates with substance-P journal September 2014
Tc-99m and Re-186 complexes of tetraphosphonate ligands and their biodistribution pattern in animal models journal February 2001
Radiosynovectomy in haemophilic synovitis of elbows and ankles: Is the effectiveness of yttrium-90 and rhenium-186 different? journal April 2016
Palliative treatment of metastatic bone pain with radiopharmaceuticals: A perspective beyond Strontium-89 and Samarium-153 journal April 2016
Preparation, characterization and evaluation of 186 Re-idarubicin: a novel agent for diagnosis and treatment of hepatocellular carcinoma: Preparation, characterization and evaluation of 186 Re-idarubicin: a novel agent for diagnosis and treatment of hepatocellular carcinoma journal January 2016
Pain Palliative Therapy in Women with Breast Cancer Osseous Metastatic Disease and the Role of Specific Serum Cytokines as Prognostic Factors journal April 2014
Radiometabolic Treatment of Bone-Metastasizing Cancer: From 186 Rhenium to 223 Radium journal February 2014
Radionuclide Therapy of Painful Bone Metastases—A Comparative Study Between Consecutive Radionuclide Infusions, Combination With Chemotherapy, and Radionuclide Infusions Alone: An In Vivo Comparison of Their Effectiveness journal December 2012
Technetium-99m, rhenium-186, and rhenium-188 direct-labeled antibodies journal February 1994
Rhenium-188 - A Generator-Derived Radioisotope for Cancer Therapy journal January 1998
Reactor-produced radionuclides at the University of Missouri Research Reactor journal April 1998
Production possibility of 186Re via the 192Os(p,α3n)186Re nuclear reaction journal July 2009
Production study of high specific activity NCA Re-186g by proton and deuteron cyclotron irradiation journal September 2010
Evaluation of charged particle induced reaction cross section data for production of the important therapeutic radionuclide 186 Re journal July 2010
Thermochromatographic separation of no-carrier-added 186 Re or 188 Re from tungsten targets relevant to nuclear medical applications journal March 2000
Production cross-sections of 181–186Re isotopes from proton bombardment of natural tungsten journal March 2007
Production and separation of 186gRe from proton bombardment of 186WC journal June 2015
Preparation of cyclotron-produced 186Re and comparison with reactor-produced 186Re and generator-produced 188Re for the labeling of bombesin journal January 2006
Excitation Functions for natW(p,xn)181-186Re Reactions and Production of No-Carrier-Added 186Re via 186W(p,n) 186Re Reaction journal January 1999
Production method of no-carrier-added186Re journal April 1996
NUCLEAR DATA MEASUREMENT OF 186 RE PRODUCTION VIA VARIOUS REACTIONS journal October 2010
Proton irradiation parameters and chemical separation procedure for the bulk production of high-specific-activity 186g Re using WO 3 targets journal May 2013
Radiochemical Study of Re/W Adsorption Behavior on a Strongly Basic Anion Exchange Resin journal January 2014
Accelerator-based production of the 99mTc-186Re diagnostic-therapeutic pair using metal disulfide targets (MoS2, WS2, OsS2) journal August 2016
Deuteron irradiation of W and WO3 for production of high specific activity 186Re: Challenges associated with thick target preparation journal September 2016
Monooxorhenium(V) complexes with 222-N2S2 MAMA ligands for bifunctional chelator agents: Syntheses and preliminary in vivo evaluation journal December 2016
Synthesis of the first radiolabeled 188 Re N -heterocyclic carbene complex and initial studies on its potential use in radiopharmaceutical applications: First radiolabeled 188 Re N -heterocyclic carbene complex journal May 2014
Non-carrier-added 186, 188Re labeled 17α-ethynylestradiol: A potential breast cancer imaging and therapy agent journal May 2001
Specific activity measurement of 64Cu: A comparison of methods journal August 2014

Cited By (2)